{"DataElement":{"publicId":"3320072","version":"1","preferredName":"Minor Component Malignant Neoplasm Intratumoral Heterogeneity Tubule Formation Percentage Score Category","preferredDefinition":"Numeric percentage and score to describe the tubule formation of a minor component with intratumoral morphologic heterogeneity characteristics.","longName":"3320063v1.0:3316555v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3320063","version":"1","preferredName":"Minor Element Malignant Neoplasm Intratumoral Heterogeneity Tubule Formation Assessment","preferredDefinition":"Lesser or smaller in amount, extent, or size._An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004 _Within a tumor._The quality or state of consisting of elements that are not of the same kind or nature._The presence of malignant tubular formations which are thought to represent malignant counterparts of the terminal ductal-lobular units of the breast._The final result of a determination of the value, significance, or extent of.","longName":"3320057v1.0:3320061v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3320057","version":"1","preferredName":"Minor Element Malignant Neoplasm","preferredDefinition":"Lesser or smaller in amount, extent, or size.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C45367:C48792:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minor","conceptCode":"C45367","definition":"Lesser or smaller in amount, extent, or size.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Element","conceptCode":"C48792","definition":"An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31CE3A1-C663-30FC-E040-BB89AD433C21","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3320061","version":"1","preferredName":"Intratumoral Heterogeneous Tubule Formation Assessment","preferredDefinition":"Within a tumor.:The quality or state of consisting of elements that are not of the same kind or nature.:The presence of malignant tubular formations which are thought to represent malignant counterparts of the terminal ductal-lobular units of the breast.:The final result of a determination of the value, significance, or extent of.","longName":"C28036:C28359:C62448:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral","conceptCode":"C28036","definition":"Within a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Heterogeneity","conceptCode":"C28359","definition":"The quality or state of consisting of elements that are not of the same kind or nature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tubule Formation","conceptCode":"C62448","definition":"The presence of malignant tubular formations which are thought to represent malignant counterparts of the terminal ductal-lobular units of the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AAC0-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AAD1-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3316555","version":"1","preferredName":"Tubule Formation Percentage Score Category","preferredDefinition":"The presence of malignant tubular formations which are thought to represent malignant counterparts of the terminal ductal-lobular units of the breast._Percentage; a fraction or ratio with 100 understood as the denominator._A number or range of numeric values measuring performance, function, quality, or ability._Category; used informally to mean a class of things.","longName":"3316555v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"16","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"not applicable (no minor component)","valueDescription":"None or Not Applicable","ValueMeaning":{"publicId":"3320040","version":"1","preferredName":"None or Not Applicable","longName":"3320040","preferredDefinition":"A term used to indicate that information on a specific question or subject can not be provided because there is no relevance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None or Not Applicable","conceptCode":"C18902","definition":"A term used to indicate that information on a specific question or subject can not be provided because there is no relevance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31C90A0-F6E7-977D-E040-BB89AD4330E1","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B31C90A0-F700-977D-E040-BB89AD4330E1","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","deletedIndicator":"No"},{"value":"score cannot be determined (NA)","valueDescription":"score cannot be determined (NA)","ValueMeaning":{"publicId":"3316556","version":"1","preferredName":"score cannot be determined (NA)","longName":"3316556","preferredDefinition":"score cannot be determined (NA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6048-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-6061-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"<10% (score = 3)","valueDescription":"<10% (score = 3)","ValueMeaning":{"publicId":"3316557","version":"1","preferredName":"<10% (score = 3)","longName":"3316557","preferredDefinition":"<10% (score = 3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-606B-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-6084-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"10-75% (score = 2)","valueDescription":"10-75% (score = 2)","ValueMeaning":{"publicId":"3316558","version":"1","preferredName":"10-75% (score = 2)","longName":"3316558","preferredDefinition":"10-75% (score = 2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-608E-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-60A7-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":">75% (score = 1)","valueDescription":">75% (score = 1)","ValueMeaning":{"publicId":"3316559","version":"1","preferredName":">75% (score = 1)","longName":"3316559","preferredDefinition":">75% (score = 1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-60B1-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-60CA-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3316554","version":"1","preferredName":"Tubule Formation Percentage Score Category","preferredDefinition":"The presence of malignant tubular formations which are thought to represent malignant counterparts of the terminal ductal-lobular units of the breast.:Percentage; a fraction or ratio with 100 understood as the denominator.:A number or range of numeric values measuring performance, function, quality, or ability.:Category; used informally to mean a class of things.","longName":"C62448:C25613:C25338:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubule Formation","conceptCode":"C62448","definition":"The presence of malignant tubular formations which are thought to represent malignant counterparts of the terminal ductal-lobular units of the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6020-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6031-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"COOPERM","dateModified":"2011-12-14","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tubule Formation of minor com","type":"Preferred Question Text","description":"Tubule Formation of minor component in cases with intratumoral heterogeneity","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-ABB0-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}